Nusse R, Clevers H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–99. https://doi.org/10.1016/j.cell.2017.05.016.

Article  CAS  PubMed  Google Scholar 

Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409–14.

Article  CAS  PubMed  Google Scholar 

Danek P, Kardosova M, Janeckova L, Karkoulia E, Vanickova K, Fabisik M, et al. beta-Catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation. Blood. 2020;136:2574–87. https://doi.org/10.1182/blood.2019004664.

Article  PubMed  PubMed Central  Google Scholar 

Brown AL, Salerno DG, Sadras T, Engler GA, Kok CH, Wilkinson CR, et al. The GM-CSF receptor utilizes beta-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation. 2012;83:47–59. https://doi.org/10.1016/j.diff.2011.08.003.

Article  CAS  PubMed  Google Scholar 

Shooshtarizadeh P, Helness A, Vadnais C, Brouwer N, Beauchemin H, Chen R, et al. Gfi1b regulates the level of Wnt/beta-catenin signaling in hematopoietic stem cells and megakaryocytes. Nat Commun. 2019;10:1270. https://doi.org/10.1038/s41467-019-09273-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luis TC, Ichii M, Brugman MH, Kincade P, Staal FJ. Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia. 2012;26:414–21. https://doi.org/10.1038/leu.2011.387.

Article  CAS  PubMed  Google Scholar 

Luis, Naber TC, Roozen BA, Brugman PP, de Haas MH, Ghazvini EF, et al. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell. 2011;9:345–56.

Article  CAS  PubMed  Google Scholar 

Morgan RG, Ridsdale J, Payne M, Heesom KJ, Wilson MC, Davidson A, et al. LEF-1 drives aberrant beta-catenin nuclear localization in myeloid leukemia cells. Haematologica. 2019;104:1365–77. https://doi.org/10.3324/haematol.2018.202846.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagstaff M, Coke B, Hodgkiss GR, and Morgan RG Targeting beta-catenin in acute myeloid leukaemia: past, present, and future perspectives. Biosci Rep. 2022; https://doi.org/10.1042/BSR20211841.

Simon M, Grandage VL, Linch DC, Khwaja A. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene. 2005;24:2410–20.

Article  CAS  PubMed  Google Scholar 

Ysebaert L, Chicanne G, Demur C, De TF, Prade-Houdellier N, Ruidavets JB, et al. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia. 2006;20:1211–6.

Article  CAS  PubMed  Google Scholar 

Griffiths EA, Golding MC, Srivastava P, Povinelli BJ, James SR, Ford LA, et al. Pharmacological targeting of beta-catenin in normal karyotype acute myeloid leukemia blasts. Haematologica. 2015;100:e49–52. https://doi.org/10.3324/haematol.2014.113118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang X, Mak PY, Mu H, Tao W, Mak DH, Kornblau S, et al. Disruption of Wnt/beta-catenin exerts antileukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia. Clin Cancer Res. 2018;24:2417–29. https://doi.org/10.1158/1078-0432.CCR-17-1556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Sheng Y, Li W, Hu C, Mittal N, Tohyama K, et al. beta-Catenin is a candidate therapeutic target for myeloid neoplasms with del(5q). Cancer Res. 2017;77:4116–26. https://doi.org/10.1158/0008-5472.CAN-17-0202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stoddart A, Wang J, Hu C, Fernald AA, Davis EM, Cheng JX, et al. Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apc(del/+) MDS mouse model. Blood. 2017;129:2959–70. https://doi.org/10.1182/blood-2016-08-736454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tonks A, Pearn L, Musson M, Gilkes A, Mills KI, Burnett AK, et al. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia. 2007;21:2495–505.

Article  CAS  PubMed  Google Scholar 

Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol. 2004;24:2890–904.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327:1650–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeung J, Esposito MT, Gandillet A, Zeisig BB, Griessinger E, Bonnet D, et al. beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell. 2010;18:606–18.

Article  CAS  PubMed  Google Scholar 

Dietrich PA, Yang C, Leung HH, Lynch JR, Gonzales E, Liu B, et al. GPR84 sustains aberrant beta-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis. Blood. 2014;124:3284–94. https://doi.org/10.1182/blood-2013-10-532523.

Article  CAS  PubMed  Google Scholar 

Fong CY, Gilan O, Lam EY, Rubin AF, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538–42. https://doi.org/10.1038/nature14888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perry JM, Tao F, Roy A, Lin T, He XC, Chen S, et al. Overcoming Wnt-beta-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nat Cell Biol. 2020;22:689–700. https://doi.org/10.1038/s41556-020-0507-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakoda T, Kikushige Y, Miyamoto T, Irifune H, Harada T, Hatakeyama K, et al. TIM-3 signaling hijacks the canonical Wnt/beta-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Blood Adv. 2023;7:2053–65. https://doi.org/10.1182/bloodadvances.2022008405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007;12:528–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351:657–67.

Article  CAS  PubMed  Google Scholar 

Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell. 2005;123:889–901. https://doi.org/10.1016/j.cell.2005.09.020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagstaff M, Tsaponina O, Caalim G, Greenfield H, Milton-Harris L, Mancini EJ, et al. Crosstalk between beta-catenin and WT1 signaling activity in acute myeloid leukemia. Haematologica. 2023;108:283–9. https://doi.org/10.3324/haematol.2021.280294.

Article  CAS  PubMed  Google Scholar 

Hodson DJ, Screen M, Turner M. RNA-binding proteins in hematopoiesis and hematological malignancy. Blood. 2019;133:2365–73. https://doi.org/10.1182/blood-2018-10-839985.